Human Umbilical Cord Mesenchymal Stem Cells Increase Interleukin-9 Production of CD4 T Cells

Overview

Journal Exp Ther Med

Specialty Pathology

Date 2017 Oct 19

PMID 29042945

Citations 4

Authors

Zhou Xin Yang

Ying Chi

Yue Ru Ji

You Wei Wang

Jing Zhang

Wei Feng Luo

Li Na Li

Cai Dong Hu

Guang Sheng Zhuo

Li Fang Wang

Zhi-Bo Han

Zhong Chao Han

Affiliations

Soon will be listed here.

Abstract

Mesenchymal stem cells (MSC) are able to differentiate into cells of multiple lineage, and additionally act to modulate the immune response. Interleukin (IL)-9 is primarily produced by cluster of differentiation (CD)4 T cells to regulate the immune response. The present study aimed to investigate the effect of human umbilical cord derived-MSC (UC-MSC) on IL-9 production of human CD4 T cells. It was demonstrated that the addition of UC-MSC to the culture of CD4 T cells significantly enhanced IL-9 production by CD4 T cells. Transwell experiments suggested that UC-MSC promotion of IL-9 production by CD4 T cells was dependent on cell-cell contact. Upregulated expression of CD106 was observed in UC-MSC co-cultured with CD4 T cells, and the addition of a blocking antibody of CD106 significantly impaired the ability of UC-MSC to promote IL-9 production by CD4 T cells. Therefore, the results of the present study demonstrated that UC-MSC promoted the generation of IL-9 producing cells, which may be mediated, in part by CD106. The findings may act to expand understanding and knowledge of the immune modulatory role of UC-MSC.

Citing Articles

Evaluation of the relationship between mesenchymal stem cells and immune system in vitro conditions.

Erol A, Abatay Sel F, Suleymanoglu M, Demirayak G, Kuruca D, Savran Oguz F Mol Biol Rep. 2023; 50(5):4347-4356.

PMID: 36935445 DOI: 10.1007/s11033-023-08374-9.

Biological Characteristics of Umbilical Cord Mesenchymal Stem Cells and Its Therapeutic Potential for Hematological Disorders.

Shang Y, Guan H, Zhou F Front Cell Dev Biol. 2021; 9:570179.

PMID: 34012958 PMC: 8126649. DOI: 10.3389/fcell.2021.570179.

Targeting stromal cell Syndecan-2 reduces breast tumour growth, metastasis and limits immune evasion.

Loftus P, Watson L, Deedigan L, Camarillo-Retamosa E, Dwyer R, OFlynn L Int J Cancer. 2020; 148(5):1245-1259.

PMID: 33152121 PMC: 7839764. DOI: 10.1002/ijc.33383.

Allogeneic umbilical cord-derived mesenchymal stem cell transplantation for treating chronic obstructive pulmonary disease: a pilot clinical study.

Le Thi Bich P, Nguyen Thi H, Dang Ngo Chau H, Phan Van T, Do Q, Dong Khac H Stem Cell Res Ther. 2020; 11(1):60.

PMID: 32054512 PMC: 7020576. DOI: 10.1186/s13287-020-1583-4.

References

Meisel R, Zibert A, Laryea M, Gobel U, Daubener W, Dilloo D . Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation. Blood. 2004; 103(12):4619-21. DOI: 10.1182/blood-2003-11-3909. View

ZuK P, Zhu M, Ashjian P, De Ugarte D, Huang J, Mizuno H . Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell. 2002; 13(12):4279-95. PMC: 138633. DOI: 10.1091/mbc.e02-02-0105. View

Aggarwal S, Pittenger M . Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood. 2004; 105(4):1815-22. DOI: 10.1182/blood-2004-04-1559. View

Dardalhon V, Awasthi A, Kwon H, Galileos G, Gao W, Sobel R . IL-4 inhibits TGF-beta-induced Foxp3+ T cells and, together with TGF-beta, generates IL-9+ IL-10+ Foxp3(-) effector T cells. Nat Immunol. 2008; 9(12):1347-55. PMC: 2999006. DOI: 10.1038/ni.1677. View

Guo Z, Zheng C, Chen Z, Gu D, Du W, Ge J . Fetal BM-derived mesenchymal stem cells promote the expansion of human Th17 cells, but inhibit the production of Th1 cells. Eur J Immunol. 2009; 39(10):2840-9. DOI: 10.1002/eji.200839070. View

Anuradha R, George P, Hanna L, Chandrasekaran V, Kumaran P, Nutman T . IL-4-, TGF-β-, and IL-1-dependent expansion of parasite antigen-specific Th9 cells is associated with clinical pathology in human lymphatic filariasis. J Immunol. 2013; 191(5):2466-73. PMC: 3764459. DOI: 10.4049/jimmunol.1300911. View

Wang D, Chen K, Du W, Han Z, Ren H, Chi Y . CD14+ monocytes promote the immunosuppressive effect of human umbilical cord matrix stem cells. Exp Cell Res. 2010; 316(15):2414-23. DOI: 10.1016/j.yexcr.2010.04.018. View

Purwar R, Schlapbach C, Xiao S, Kang H, Elyaman W, Jiang X . Robust tumor immunity to melanoma mediated by interleukin-9-producing T cells. Nat Med. 2012; 18(8):1248-53. PMC: 3518666. DOI: 10.1038/nm.2856. View

Ciprandi G, De Amici M, Giunta V, Marseglia A, Marseglia G . Serum interleukin-9 levels are associated with clinical severity in children with atopic dermatitis. Pediatr Dermatol. 2012; 30(2):222-5. DOI: 10.1111/j.1525-1470.2012.01766.x. View

10.

Elyaman W, Bradshaw E, Uyttenhove C, Dardalhon V, Awasthi A, Imitola J . IL-9 induces differentiation of TH17 cells and enhances function of FoxP3+ natural regulatory T cells. Proc Natl Acad Sci U S A. 2009; 106(31):12885-90. PMC: 2722314. DOI: 10.1073/pnas.0812530106. View

11.

Bu X, Zhou Q, Zhang J, Ye Z, Tong Z, Shi H . Recruitment and phenotypic characteristics of interleukin 9-producing CD4+ T cells in malignant pleural effusion. Lung. 2013; 191(4):385-9. DOI: 10.1007/s00408-013-9474-4. View

12.

Lu L, Liu Y, Yang S, Zhao Q, Wang X, Gong W . Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials. Haematologica. 2006; 91(8):1017-26. View

13.

Veldhoen M, Uyttenhove C, Van Snick J, Helmby H, Westendorf A, Buer J . Transforming growth factor-beta 'reprograms' the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset. Nat Immunol. 2008; 9(12):1341-6. DOI: 10.1038/ni.1659. View

14.

Nemeth K, Keane-Myers A, Brown J, Metcalfe D, Gorham J, Gorham J . Bone marrow stromal cells use TGF-beta to suppress allergic responses in a mouse model of ragweed-induced asthma. Proc Natl Acad Sci U S A. 2010; 107(12):5652-7. PMC: 2851758. DOI: 10.1073/pnas.0910720107. View

15.

Jiang Y, Jahagirdar B, Reinhardt R, Schwartz R, Keene C, Ortiz-Gonzalez X . Pluripotency of mesenchymal stem cells derived from adult marrow. Nature. 2002; 418(6893):41-9. DOI: 10.1038/nature00870. View

16.

Sun J, Han Z, Liao W, Yang S, Yang Z, Yu J . Intrapulmonary delivery of human umbilical cord mesenchymal stem cells attenuates acute lung injury by expanding CD4+CD25+ Forkhead Boxp3 (FOXP3)+ regulatory T cells and balancing anti- and pro-inflammatory factors. Cell Physiol Biochem. 2011; 27(5):587-96. DOI: 10.1159/000329980. View

17.

Wong M, Ye J, Alonso M, Landrigan A, Cheung R, Engleman E . Regulation of human Th9 differentiation by type I interferons and IL-21. Immunol Cell Biol. 2010; 88(6):624-31. PMC: 3090036. DOI: 10.1038/icb.2010.53. View

18.

English K, Ryan J, Tobin L, Murphy M, Barry F, Mahon B . Cell contact, prostaglandin E(2) and transforming growth factor beta 1 play non-redundant roles in human mesenchymal stem cell induction of CD4+CD25(High) forkhead box P3+ regulatory T cells. Clin Exp Immunol. 2009; 156(1):149-60. PMC: 2673753. DOI: 10.1111/j.1365-2249.2009.03874.x. View

19.

Ren G, Zhang L, Zhao X, Xu G, Zhang Y, Roberts A . Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. Cell Stem Cell. 2008; 2(2):141-50. DOI: 10.1016/j.stem.2007.11.014. View

20.

Gregersen I, Skjelland M, Holm S, Holven K, Krogh-Sorensen K, Russell D . Increased systemic and local interleukin 9 levels in patients with carotid and coronary atherosclerosis. PLoS One. 2013; 8(8):e72769. PMC: 3758349. DOI: 10.1371/journal.pone.0072769. View